Table of Content

1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study


2 RESEARCH METHODOLOGY


3 EXECUTIVE SUMMARY


4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Incidence of Breast Cancer
4.2.2 Increasing Government Initiatives and Support
4.2.3 Technological Advancements
4.3 Market Restraints
4.3.1 Controversies Related to Mammography
4.3.2 Side Effects of Radiation during Screening Tests and Errors in Screening
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry


5 MARKET SEGMENTATION
5.1 By Test
5.1.1 Genomic Tests
5.1.2 Imaging Test
5.1.2.1 Mammogram
5.1.2.2 Ultrasound
5.1.2.3 MRI
5.1.2.4 Tomography
5.1.2.5 Other Imaging Tests
5.2 Geography
5.2.1 North America
5.2.1.1 United States
5.2.1.2 Canada
5.2.1.3 Mexico


6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Allengers Medical Systems Limited
6.1.2 Fujifilm Holdings Corporation
6.1.3 Hologic Inc.
6.1.4 GE Healthcare
6.1.5 Myriad Genetics
6.1.6 QIAGEN NV
6.1.7 Quest Diagnostics Incorporated
6.1.8 Siemens Healthineers


7 MARKET OPPORTUNITIES AND FUTURE TRENDS